Daiichi Sankyo Escapes Antitrust MDL Over Generic Lipitor
A New Jersey federal judge on Monday released Daiichi Sankyo Inc. from multidistrict antitrust litigation challenging a patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Inc. over Pfizer's cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article